Supplementary Table S2

Selected clinical trials showing association of MMF with diseases suggested to be associated with MMF molecular footprint by synlet enrichment between or within pathways. Only the drug association determined by synlet associated pathways is indicated, even if multiple drugs are used in a trial (as is often the case). Importantly, few trials were designed to differentiate MMF use from other drug combinations, yet apply MMF as part of basic treatment or within a list of potential treatment options.